Elucidating glycosaminoglycan–protein–protein interactions using carbohydrate microarray and computational approaches by Rogers, Claude J. et al.
Elucidating glycosaminoglycan–protein–protein
interactions using carbohydrate microarray
and computational approaches
Claude J. Rogersa,1, Peter M. Clarka,1, Sarah E. Tullya, Ravinder Abrolb, K. Christopher Garciac,
William A. Goddard IIIb,d, and Linda C. Hsieh-Wilsona,2
aCalifornia Institute of Technology and Howard Hughes Medical Institute, Division of Chemistry and Chemical Engineering, 1200 East California
Boulevard, Pasadena, CA 91125; bMaterials and Process Simulation Center, California Institute of Technology, Division of Chemistry and Chemical
Engineering, 1200 East California Boulevard, Pasadena, CA 91125; cStanford University School of Medicine and Howard Hughes Medical Institute,
Departments of Molecular and Cellular Physiology and Structural Biology, Stanford, CA 94305; and dGraduate School of EEWS (WCU), Korea Advanced
Institute of Science Technology, Daejeon, 305-701, Korea
Edited by Chi-Huey Wong, Academia Sinica, Taipei, Taiwan, and approved May 4, 2011 (received for review February 25, 2011)
Glycosaminoglycan polysaccharides play critical roles in many
cellular processes, ranging from viral invasion and angiogenesis to
spinal cord injury. Their diverse biological activities are derived
from an ability to regulate a remarkable number of proteins. How-
ever, few methods exist for the rapid identification of glycosami-
noglycan–protein interactions and for studying the potential of
glycosaminoglycans to assemble multimeric protein complexes.
Here, we report a multidisciplinary approach that combines new
carbohydrate microarray and computational modeling methodol-
ogies to elucidate glycosaminoglycan–protein interactions. The
approach was validated through the study of known protein part-
ners for heparan and chondroitin sulfate, including fibroblast
growth factor 2 (FGF2) and its receptor FGFR1, the malarial protein
VAR2CSA, and tumor necrosis factor-α (TNF-α). We also applied
the approach to identify previously undescribed interactions be-
tween a specific sulfated epitope on chondroitin sulfate, CS-E,
and the neurotrophins, a critical family of growth factors involved
in the development, maintenance, and survival of the vertebrate
nervous system. Our studies show for the first time that CS is
capable of assembling multimeric signaling complexes and modu-
lating neurotrophin signaling pathways. In addition, we identify
a contiguous CS-E-binding site by computational modeling that
suggests a potential mechanism to explain how CS may promote
neurotrophin-tyrosine receptor kinase (Trk) complex formation
and neurotrophin signaling. Together, our combined microarray
and computational modeling methodologies provide a general,
facile means to identify new glycosaminoglycan–protein–protein
interactions, as well as a molecular-level understanding of those
complexes.
Glycosaminoglycans (GAGs) regulate a wide range of physio-logical processes, including viral invasion, blood coagulation,
cell growth, and spinal cord injury (1–4). Assembled from repeat-
ing disaccharide units, GAGs display diverse patterns of sulfation
(SI Appendix, Fig. S1). These sulfation patterns are believed to
have important functional consequences, enabling the polysac-
charides to interact with a wide variety of proteins (1, 2). How-
ever, the precise sulfation motifs involved in protein recognition
are understood in only a few cases (1, 4, 5). Moreover, studies of
heparan sulfate (HS) interactions with fibroblast growth factors
suggest that GAGs can assist in the assembly of multimeric pro-
tein complexes, thereby modulating signal transduction pathways
(6–10). Yet, only a few such examples have been elucidated, and
the extent to which other GAGs such as chondroitin sulfate (CS)
engage in the formation of multimeric protein complexes remains
unknown. Elucidating the interactions of specific GAG substruc-
tures with proteins and large protein–protein complexes will be
critical for understanding the structure-activity relationships of
GAGs and the mechanisms underlying important biological
processes.
Several methods have been developed to study GAG–protein
interactions, including affinity chromatography, analytical ultra-
centrifugation, electrophoretic mobility shift assays, competition
experiments, mass spectrometry-based approaches, isothermal
titration calorimetry, and surface plasmon resonance (9–16).
Although powerful, these approaches are low throughput, often
labor intensive, and require significant quantities of carbohydrate
and/or protein. Notably, no methods are available to rapidly
screen various GAGs for their ability to assemble multimeric pro-
tein complexes. In addition, existing methods often require oligo-
saccharides or polysaccharides that are relatively homogeneous
in chain length and charge density, such as fractionated heparin
or chemically modified HS (11, 12, 14). As such, it has been
difficult to study the interactions of proteins with other GAG
classes and physiologically relevant GAG preparations, which are
more heterogeneous and structurally diverse.
Similarly, structural studies of GAG–protein interactions have
been limited by the complexity and heterogeneity of naturally
occurring GAGs. For example, the majority of crystal structures
contain fully sulfated heparin oligosaccharides instead of the
physiological HS ligands of lower charge density (17). As an
alternative strategy, recent advances in molecular modeling
have provided several approaches for understanding the interac-
tion of heparin or HS with proteins, including IL-8, TSG-6,
and PECAM-1 (18–20). However, GAG–protein interactions
pose a unique set of challenges for computational modeling,
such as highly flexible sugar ligands with many rotatable bonds,
interaction energies dominated by electrostatics, and shallow,
solvent-accessible binding pockets. Importantly, computational
approaches have not yet been applied to other GAGs, such as
the less highly charged CS class, nor have they been developed
to investigate large GAG–protein–protein complexes.
Here, we describe an integrated approach that combines
carbohydrate microarray methodologies with computational
modeling to provide unique insights into GAG interactions with
proteins and multimeric protein complexes. We demonstrate that
carbohydrate microarrays can be used to rapidly screen proteins
and protein–protein complexes for binding to specific sulfation
motifs and GAG classes. Such information can then be used
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in conjunction with previously undescribed computational mod-
eling approaches to predict GAG-binding sites within proteins
and to determine the potential for GAGs to assemble multimeric
protein complexes. Using this combined approach, we identify a
specific interaction between the sulfated chondroitin sulfate-E
(CS-E, SI Appendix, Fig. S1) epitope and the neurotrophin
(NT) family of growth factors and receptors. Our computational
modeling results suggest a contiguous CS-E-binding site that
spans the NT–tyrosine receptor kinase (Trk) complex, providing
a potential mechanism to explain how CS modulates complex
formation and NT signaling pathways. Together with cellular
data, we provide evidence that CS plays an active role in cellular
signaling by regulating the interactions between growth factors
and their receptors.
Results and Discussion
General Microarray Approach. The binding of proteins to GAGs
was examined using carbohydrate microarrays containing either
synthetic tetrasaccharides of defined sulfation sequence (21, 22)
or naturally occurring polysaccharides representing various GAG
classes (23). Microarrays of synthetic tetrasaccharides displaying
the CS-A, CS-C, or CS-E sulfation motifs (SI Appendix, Fig. S1)
were robotically printed on aldehyde-coated glass surfaces at
varying concentrations (1–300 μM). Polysaccharide microarrays
were printed on poly-DL-lysine-coated glass surfaces and con-
tained varying concentrations (0.25–25 μM) of chondroitin
sulfate enriched in the CS-A, CS-C, CS-D, CS-E motifs, derma-
tan sulfate (CS-B), hyaluronic acid (HA), heparin (Hep), heparan
sulfate (HS), or keratan sulfate (KS). In all cases, the microarrays
were incubated with the protein or protein–protein complex
of interest, and binding was detected using primary antibodies
against the protein(s) followed by secondary Cy3- and/or Cy5-la-
beled antibodies. Notably, this miniature array format permitted
the rapid detection of multiple binding events simultaneously
and required minimal amounts (1–100 μg) of carbohydrate and
protein. As described below, the arrays allowed for comparisons
of the binding of large families or functional classes of proteins to
various GAG subtypes to provide a more comprehensive under-
standing of the specificity of proteins for different GAGs classes
and sulfation sequences. We also applied the microarray tech-
nology toward the discovery of previously undescribed GAG–
protein interactions and toward an understanding of the assembly
of multimeric protein complexes.
General Computational Approach.Once GAG–protein interactions
were identified using carbohydrate microarrays, we predicted the
GAG binding sites on proteins using computational methods.
First, rigid-body docking of one oligosaccharide conformation
to the entire molecular surface of the protein was performed
to locate the most favorable binding sites (24). Next, rigid-body
docking of the oligosaccharide conformation into those binding
sites was continued until a diverse set of ligand orientations with
respect to the protein was obtained (25). The protein side chains
in the binding sites were then optimized (26), and the energy of
the entire oligosaccharide–protein complex was minimized.
Residues within 5 Å of the oligosaccharide in more than one of
the five minimum energy structures were considered part of the
GAG binding site.
Approach Validation. VAR2CSA. To test the computational methods,
we first examined the protein VAR2CSA, a CS-A-binding protein
involved in placental malaria pathogenesis (27). CS-A binds to
the DBL3x and DBL6 (Duffy binding-like 3x and 6) domains
of VAR2CSA with micromolar affinity, and basic residues impor-
tant for the interaction have been identified by site-directed
mutagenesis (28). In addition, 1.8- and 3.0-Å crystal structures
of the DBL3x and DBL6 domains of VAR2CSA, respectively,
have been solved (28, 29). We predicted the lowest energy con-
formation of a CS-A tetrasaccharide by performing molecular
dynamics simulations in explicit water (22) and used ScanBind-
Site and GenMSCDock to determine the CS-A binding site on
DBL3x or DBL6. CS-A was found to interact with both of the
lysine residues predicted by mutagenesis to comprise the primary
CS-A binding site on DBL6 (Fig. 1A and SI Appendix, Table S1).
Moreover, five of the seven residues determined to be important
for CS-A binding to DBL3x were successfully identified, further
validating the computational approach (Fig. 1B and SI Appendix,
Table S2). The side chain of Lys1515, one of the residues not
identified by computational modeling, is buried in the crystal
structure and makes electrostatic contacts with two internal
Glu residues (Glu1464 and Glu1518), suggesting that this residue
may not engage directly in interactions with CS-A. Together,
these results show that CS binding sites on proteins can be cor-
rectly identified using our computational approach. Furthermore,
we identify additional residues within DBL6 and DBL3x that may
participate in close van der Waals and other interactions with
the sugar.
Fibroblast growth factor 2 (FGF2) and its complex with FGF receptor 1
(FGFR1). To further test our computational methods, we modeled
the heparin binding site on FGF2 and extended our approach to
the larger FGF2-FGFR1 complex. Using the solution structure of
FGF2 and the crystal structure of a heparin tetrasaccharide, we
identified all of the charged residues, as well as six of the seven
other residues, located within 5 Å of heparin in the cocrystal
structure of FGF2 complexed to a tetrasaccharide (Fig. 1C
and SI Appendix, Table S3) (30). Two additional contacts were
predicted using our computational approach, one of which
(Lys26) is found in the cocrystal structure of FGF2 bound to a
heparin hexaccharide (30).
Having correctly predicted the heparin binding site, we next
tested whether our computational approach could be used to pro-
vide insight into the interaction of GAGs with large, multimeric
protein complexes. Biochemical, structural, and cellular studies
have established that heparin forms a ternary complex with
FGF2 and the FGFR1 receptor and makes multiple contacts with
both proteins (7, 31). Initial attempts to dock a heparin octasac-
charide to the FGF2-FGFR1 complex identified only the heparin
binding site on FGFR1. To overcome this problem, we deter-
Fig. 1. (A and B) CS-A binding site (blue) on the DBL6 (A) and DBL3x
(B) domains of VAR2CSA, as predicted by computational modeling (Left)
and mutagenesis (Right). (C) Hep binding site (blue) on FGF2 as predicted
computationally (Left) and determined crystallographically (Right). (D) Hep
binding site (blue) in the FGF2-FGFR1 complex as predicted computationally
(Left) and determined crystallographically (Right). The two FGF2 subunits are
shown in green and orange, and the two FGFR1 subunits are shown in light
blue and gray. (E) Predicted CS-E binding site (blue) in the trimeric structure of
TNF-α (Left). Homology model of the TNF-α-TNFR1 complex (Right) shows
that the CS-E binding site overlaps with the TNFR1 binding site. TNFR1 is
depicted in gray.
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mined each of the heparin binding sites on FGF2 and FGFR1
individually and superimposed those binding sites onto the struc-
ture of the FGF2-FGFR1 complex. The majority of the residues
found in the sugar binding site of the heparin-FGF2-FGFR1 crys-
tal structure were identified (Fig. 1D and SI Appendix, Table S4).
Most importantly, we observed a contiguous binding site that
spanned the FGF2-FGFR1 complex, consistent with the crystal
structure. Thus, our computational methods can be used to pre-
dict GAG binding sites and to provide insights into the potential
for GAGs to assemble multimeric protein complexes.
The ability of HS to mediate the formation of protein
complexes is critical for its biological functions, enabling it to
regulate growth factor, chemokine, and other signal transduction
pathways (8, 32). As experimental methods for studying carbo-
hydrate-mediated protein–protein interactions require consider-
able material and are low throughput, we sought to expand
carbohydrate microarray methodologies to rapidly screen for
carbohydrate–protein–protein complexes. We chose the well-
established heparin-FGF2-FGFR1 interaction as our first test
case. FGF2, FGFR1-Fc fusion protein, or a 1∶1mixture of FGF2:
FGFR1-Fc was incubated with the polysaccharide microarrays,
and after treatment with a primary antibody against FGF2,
growth factor or receptor binding was detected using orthogonal
secondary antibodies conjugated to Cy3 or Cy5 dyes. We found
that FGF2 bound strongly to heparin and HS polysaccharides in
the absence of FGFR1 (Fig. 2A), whereas FGFR1 alone showed
minimal binding to the array (Fig. 2B). Notably, FGFR1 binding
increased significantly in the presence of FGF2, suggesting that
binding of the growth factor to heparin or HS enhances binding
of the receptor. Moreover, colocalization of both proteins was
detected on the arrays (SI Appendix, Fig. S2), indicating the
formation of carbohydrate–protein–protein complexes. Complex
formation was observed with heparin, HS, and, to a lesser extent,
with CS-E-enriched polysaccharides, consistent with the demon-
strated selectivity of FGFs for these GAG subclasses (12, 23).
Tumor necrosis factor-α (TNF-α) and its complex with TNF receptor 1
(TNFR1). As final validation of our computational and carbohy-
drate microarray approaches, we examined the interaction of
CS with TNF-α, a proinflammatory cytokine involved in autoim-
mune diseases such as rheumatoid arthritis, Crohn’s disease, and
psoriasis (33, 34). Previous studies in our laboratory have demon-
strated that a tetrasaccharide displaying the CS-E sulfation motif
binds to TNF-α and antagonizes its interaction with TNFR1,
thereby inhibiting TNF-α-induced cell death (21). To test our
microarray approach, we incubated TNF-α, TNFR1-Fc, or a
1∶1mixture of TNF-α:TNFR1-Fc with CS tetrasaccharide micro-
arrays. Both TNF-α and TNFR1-Fc selectively bound to CS-E
tetrasaccharides when incubated alone with the microarrays
(SI Appendix, Fig. S3). However, binding of these proteins to
CS-E was abolished when the proteins were incubated together.
These data indicate that once formed, the TNF-α-TNFR1 com-
plex cannot bind to CS-E tetrasaccharides on the array. Thus,
CS-E, TNF-α, and TNFR1 do not appear to form a ternary com-
plex, consistent with previous studies (21) and further validating
the use of microarrays to rapidly probe the interactions of GAGs
with multimeric protein complexes.
We next applied our computational approach to gain insight
into the CS-E binding site on TNF-α. We found that CS-E binds
predominantly to two loops between antiparallel β-strands c–d of
monomer A and β-strands e–f of monomer B in the TNF-α trimer
structure (Fig. 1E and SI Appendix, Table S5). As the structure
displays 3-fold symmetry, CS-E binding sites are also predicted
between monomers B and C, and C and A. Additionally, in sup-
port of our model, we found that the average binding energies
of CS-A and CS-C at this site were significantly worse than the
average binding energy of CS-E (SI Appendix, Table S6). We con-
structed a homology model of the TNF-α-TNFR1 complex based
on the known crystal structure of the TNF-β-TNFR1 complex).
Notably, the CS-E binding site on TNF-α overlaps with that of
TNFR1, as determined by site-directed mutagenesis (35) and
homology modeling. These findings are consistent with the car-
bohydrate microarray results above and with previous ELISA and
cellular studies (21), further validating the computational meth-
ods. Collectively, we have shown that the integration of computa-
tional modeling and microarray approaches can be used to gain
important insights into GAG–protein interactions and to rapidly
establish whether specific GAG subclasses or sulfation motifs
interact with multimeric protein complexes.
Identification of New Glycosaminoglycan–Protein Interactions: The
NTs and Their Receptors. The NTs have critical functions in many
aspects of neuronal development, including neurite outgrowth,
cell survival, differentiation, and proliferation (36, 37). They also
play important roles in synaptic plasticity and maintenance of
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Fig. 2. (A) Relative binding of FGF2 to the indicated glycosaminoglycan
(0.5-, 5-, and 10-μM concentration) on polysaccharide microarrays in the
presence (red) or absence (black) of FGFR1. (B) Relative binding of FGFR1
to the indicated glycosaminoglycan (0.5-, 5-, and 10-μM concentration) on
polysaccharide microarrays in the presence (red) or absence (black) of
FGF2. (C) Relative binding of NGF, BDNF, NT-3, and NT-4∕5 to the indicated
CS tetrasaccharide on carbohydrate microarrays. (D) Relative binding of
the Trk receptors to CS tetrasaccharides on carbohydrate microarrays in
the presence (red) or absence (black) of the indicated NTs. (E) Comparison
of the relative binding of TrkA to CS-E-enriched polysaccharides in the
presence of NGF, NT-3, or NT-4∕5. Binding relative to the maximum signal
for each plot is shown in A–C and E; binding relative to the maximum signal-
ing for the series of two plots is shown in D. Each protein was analyzed
in triplicate, and the data represent an average of 8–10 spots for a given
carbohydrate concentration.
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the adult nervous system (36–38) and have been implicated in
neurodegenerative diseases (36). Previously, we found that a
tetrasaccharide containing a specific sulfation motif, CS-E,
stimulates the outgrowth of developing hippocampal neurons
(22, 39). Our studies implicated brain-derived neurotrophic
factor (BDNF) as one of the proteins responsible for mediating
the effects of CS-E (22). In addition to BDNF, the NT family
includes nerve growth factor (NGF), neurotrophin-3 (NT-3), and
neurotrophin-4∕5 (NT-4∕5), which share approximately 50%
sequence homology to BDNF and strikingly similar structures,
with rmsd of less than 2 Å between any two NTs. We used our
microarray approach to rapidly compare the binding specificity
across this protein family. Notably, all of the NTs showed concen-
tration-dependent binding to CS-E tetrasaccharides, with NGF
displaying the greatest specificity (Fig. 2C). However, the ability
of BDNF and other NTs to bind weakly to other sulfation motifs
was unexpected, given that only the CS-E motif stimulated
neurite outgrowth (22, 39). Thus, we postulated that CS-E might
interact with additional proteins, possibly forming protein–
protein complexes between NTs and their receptors and that the
formation of such complexes might impart greater selectivity for
the CS-E motif.
To test this hypothesis, we examined the binding of various
NT-receptor pairs to CS tetrasaccharide and polysaccharide
microarrays. The NTs activate signal transduction pathways by
binding to the Trk receptors A, B, and C (36, 37, 40, 41). In par-
ticular, TrkA binds to NGF, TrkB binds to BDNF and NT-4∕5,
and TrkC binds to NT-3. However, “cross-talk” among the NT
family has also been observed, whereby certain NTs bind to ad-
ditional Trk receptors with lower affinity (e.g., NT-3 and NT-4∕5
to TrkA) (36, 42). This cross-talk raises the interesting question of
how specific NT signaling pathways are differentially activated
in vivo.
We first probed the ability of CS-E to assemble NT-Trk com-
plexes, starting with the primary-binding partners NGF-TrkA,
BDNF-TrkB, NT-3-TrkC, and NT-4∕5-TrkB. In the absence of
NT, TrkA and TrkB bound weakly to the CS-E tetrasaccharide,
whereas TrkC showed no apparent binding to the microarray
(Fig. 2D and SI Appendix, Fig. S4). Notably, the presence of
NGF and BDNF significantly enhanced the binding of TrkA
and TrkB, respectively, to CS-E, and colocalization of the pro-
teins was observed on the array, suggesting the formation of
CS-E-NGF-TrkA and CS-E-BDNF-TrkB complexes. Complex
assembly was highly selective for the CS-E sulfation motif and
did not occur in the presence of CS-A or CS-C tetrasaccharides.
Similar results were obtained using polysaccharide microarrays
(SI Appendix, Fig. S5). Thus, the complex of NTand Trk showed
greater selectivity for CS-E than each NT alone, reinforcing
the notion that formation of GAG–protein–protein complexes
can impart greater selectivity for specific sulfation motifs. Inter-
estingly, NT-3 and NT-4∕5 did not increase the binding of
TrkC and TrkB to CS-E tetra- or polysaccharides, respectively
(SI Appendix, Figs. S4 and S5), suggesting that CS-E forms
complexes only with certain NT-receptor pairs and raising the
possibility that the spatiotemporal expression of CS-E in vivo
may differentially regulate specific NT signaling pathways.
We next investigated the secondary cross-talk between the NTs
and their receptors. Specifically, TrkA binding to the arrays was
evaluated in the presence or absence of NGF, NT-3, or NT-4∕5.
Selective, but weak, binding of TrkA to CS-E-enriched polysac-
charides was observed in the absence of NT (Fig. 2E and
SI Appendix, Fig. S5). Addition of NGF, NT-3, or NT-4∕5 signif-
icantly increased the binding of TrkA to the array (Fig. 2E),
suggesting that CS-E is capable of forming complexes with NGF-
TrkA, NT-3-TrkA, and NT-4∕5-TrkA. Interestingly, TrkA binding
to CS-E was enhanced the most by the presence of NT-4∕5,
followed by NT-3. In the absence of CS-E, however, TrkA
showed the greatest binding affinity for NGF, followed by NT-3,
and NT-4∕5, as measured by ELISA (SI Appendix, Fig. S6) and
consistent with previous reports (40). Thus, the ability of CS-E to
enhance receptor binding was inversely related to the relative
affinity of the NT-TrkA interaction. These results suggest that
CS-E may help to stabilize weaker NT-receptor interactions and
may enable activation of secondary NT signaling pathways.
To gain molecular-level insights, we computationally modeled
the CS-E binding sites in the NTand NT-receptor complexes. The
CS-E tetrasaccharide structure (22) was first docked to known
crystal structures of human NGF, NT-3, or NT-4∕5 dimers. For
the BDNF dimer structure, we built a homology model by repla-
cing NT-3 with BDNF in the BDNF-NT-3 dimer structure. We
found that the predicted CS-E binding sites share several com-
mon features (Fig. 3A and SI Appendix, Figs. S7 and S8 and
Table S7). First, each site contains a high density of basic amino
acids, ranging from four in the case of the NT-4∕5 dimer to seven
in the case of the NT-3 dimer. Although these basic residues are
highly conserved across many species for a given NT, they are
not entirely conserved among different NT family members
(SI Appendix, Fig. S7), which may explain in part the observed
differences in selectivity and affinity for CS-E. Second, each site
contains lysine and arginine residues separated by distances that
would allow them to interact with multiple sulfate groups on the
CS-E tetrasaccharide. For example, the average distance between
the sulfur atoms of the sulfate groups in the same disaccharide of
CS-E is 5.5 Å and in adjacent disaccharides is 12.9 Å. In the CS-E
binding site on NGF, the ϵ-amino groups of Lys32 and Lys34 are
5.6 Å apart and an average distance of 12.7 Å away from the
ϵ-amino group of Lys95. Notably, we found that in each case,
the average binding energy of CS-E was much lower than that
of either CS-A or CS-C (SI Appendix, Table S6), although we
could not resolve the relative binding energies of CS-A and
CS-C due to their weaker binding interactions with the NT.
We also observed some differences in the CS-E binding sites
among NT family members. Overall, CS-E bound to the BDNF,
NGF, and NT-4∕5 dimers in a similar manner, interacting with
residues within loop 1, loop 4, and β-strand 8 of monomer A
(SI Appendix, Fig. S7). However, CS-E also made contacts with
residues in loop 2 and β-strands 5 and 6 of monomer B in BDNF
and NGF. The predicted CS-E binding site on the NT-3 dimer was
the most distinct. Many of the basic residues found in the binding
sites of BDNF, NGF, and NT-4∕5 were absent in NT-3 and vice
versa, and CS-E interacted primarily with residues in loop 3 and
β-strands 5 and 6 of monomer A (corresponding to β-strands 7
NGF BDNF NT-3 NT-4/5A TrkA TrkBB
NGF-TrkAC BDNF-
TrkB
NT-4/5-
TrkA
NT-3-
TrkA
Fig. 3. (A) Predicted CS-E binding site [blue (nonbasic residues) and yellow
(basic residues)] in the BDNF, NGF, NT-4∕5, and NT-3 dimer. (B) Predicted
CS-E binding site [blue (nonbasic residues) and yellow (basic residues)] in
the NT binding domain (domain 5) of TrkA and TrkB. (C) Predicted CS-E
binding sites [blue (nonbasic residues) and yellow (basic residues)] in the
BDNF-TrkB, NGF-TrkA, NT-4∕5-TrkA, and NT-3-TrkA complexes. The CS octa-
saccharides were manually docked.
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and 8 of the other NTs). Although residues in loop 3 were not well
resolved in the human NGF and NT-4∕5 crystal structures used
for our modeling studies, we confirmed that the CS-E interaction
with loop 3 was unique to NT-3 by modeling the CS-E binding site
in the mouse NGF crystal structure and a different human
NT-4∕5 structure, both of which contain a highly resolved struc-
ture for loop 3. In both cases, the CS-E binding site was
unchanged by the presence of loop 3, suggesting a distinct mode
of binding to NT-3.
We next modeled the CS-E binding sites in the Trk receptors by
docking the CS-E tetrasaccharide structure to known crystal
structures of the ligand binding domains of TrkA and TrkB. In
contrast to the CS-E binding sites on the NTs, the binding sites
on TrkA and TrkB comprised primarily β-strands (specifically
β-strand C, F, and G) rather than loops, and they contained
only two basic residues (Fig. 3B and SI Appendix, Fig. S8 and
Table S7). The presence of fewer basic residues in the binding
site may account for the weaker binding affinity of CS-E for
the Trks compared to the NTs. Importantly, the CS-E binding
sites on TrkA and TrkB showed no overlap with the NT interac-
tion surface, suggesting that the sugar binds to a distinct site on
the receptor. Indeed, superimposing the CS-E binding sites
for each protein onto the NGF-TrkA crystal structure or the
BDNF-TrkB, NT-3-TrkA, and NT-4∕5-TrkA homology models
revealed a contiguous sugar binding site that spanned a single
face of the complex (Fig. 3C and SI Appendix, Fig. S9). As the
structures of the NT-Trk complex have C2 symmetry, a second
CS-E binding site is predicted that would enable formation of
a 2∶2∶2 complex. Each sugar binding site readily accommodates
a single octasaccharide, suggesting a molecular mechanism by
which CS polysaccharides might assist in the assembly of NT-
Trk receptor complexes and promote NT signaling.
As independent confirmation of our microarray and computa-
tional results, we performed several cellular studies. Pheochro-
mocytoma 12 (PC12) cells express high levels of TrkA and
have been used extensively to study NGF-TrkA signaling path-
ways (43, 44). We first examined whether the CS-E motif was
expressed on PC12 cells using a CS-E-specific monoclonal anti-
body developed by our laboratory (22, 39). We observed strong
CS-E-positive staining on the cell surface, which could be
removed using chondroitinase ABC (ChABC), an enzyme that
hydrolyzes CS chains (SI Appendix, Fig. S10). Notably, removal
of endogenous CS-E polysaccharides on PC12 cells significantly
attenuated TrkA activation by NGF or NT-4∕5 by 24 7% and
37 3%, respectively, as measured using a phospho-TrkA anti-
body (Fig. 4A). The greater effect of CS on NT-4∕5-induced
activation of TrkA compared to NGF is consistent with our
microarray data (Fig. 2E) indicating that CS-E enhances the
NT-4∕5-TrkA interaction more than that of NGF-TrkA. These
results further support the notion that CS-E promotes the for-
mation of specific NT-Trk complexes and the activation of NT
signaling pathways.
Similarly, we found that CS-E-enriched polysaccharides
adsorbed onto a substratum activated NT-4∕5-mediated TrkA
signaling by 42 6%, but had no appreciable effect on NGF-
mediated TrkA signaling at the CS-E concentration tested
(Fig. 4B). Furthermore, the addition of exogenous CS-E-enriched
polysaccharides to the medium interfered with NT signaling,
reducing NGF- and NT-4∕5-mediated TrkA activation by 19
2% and 49 11%, respectively (Fig. 4C). A greater reduction
(81 1%) in NGF-induced TrkA activation was achieved by using
a tenfold higher concentration of polysaccharide, indicating that
CS-E can modulate NGF-TrkA interactions, albeit less effectively
compared to NT-4∕5-TrkA interactions. These findings are con-
sistent with previous studies that have shown stimulatory effects
on neurite outgrowth for adsorbed CS (22, 39, 45) and inhibitory
effects for CS in solution (46–48). Our data support the model
that CS-E polysaccharides on cell-surface proteoglycans or
coated on a substratum recruit NTs to the cell surface, thereby
promoting complex formation and stimulating NTsignaling path-
ways. By adding exogenous CS-E in solution, the polysaccharide
acts as a competitive inhibitor, sequestering NTs away from the
cell surface and thereby disrupting NT-mediated signaling (47).
Finally, we found that prolonged exposure of PC12 cells to NGF
increased the colocalization of TrkA and CS-E by 2.3 0.1-fold
(Fig. 4D). As TrkA is known to form signaling endosomes in PC12
cells after prolonged exposure to NGF (49), these findings lend
further support to the notion that CS-E is a key component of
the NGF-TrkA signaling complex.
Collectively, our microarray, computational and cellular
studies demonstrate that NT-Trk interactions and signaling path-
ways are modulated by CS-E polysaccharides. Furthermore, we
suggest that NT-4∕5-TrkA pathways should be more sensitive
than NGF-TrkA pathways to CS-E levels. More broadly, these
results provide evidence that CS GAGs regulate this important
family of growth factors and function in the assembly of multi-
meric signaling complexes.
Conclusion
We have developed carbohydrate microarray and computational
modeling approaches for the rapid screening and understanding
of GAG interactions with proteins and multimeric protein com-
plexes. Using these methods, we identify previously undescribed
interactions between a specific sulfated epitope, CS-E, and the
neurotrophin family of growth factors. Moreover, we show that
CS is capable of assembling multimeric signaling complexes and
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Fig. 4. CS-E modulates NGF- or NT-4∕5-mediated TrkA activation in cells. (A) Removal of endogenous CS-E on PC12 cells using ChABC reduced NGF- and
NT-4∕5-mediated TrkA phosphorylation. (B) CS-E-enriched polysaccharides enhanced TrkA phosphorylation by NT-4∕5, but not NGF, when coated
on a substratum at 500 ng · mL−1. (C) Addition of exogenous CS-E (500 ng · mL−1) to the media reduced NGF-induced and NT-4∕5-induced TrkA phosphoryla-
tion. NGF-induced activation was further inhibited by higher concentrations (5;000 ng · mL−1) of CS-E. For A–C, relative TrkA activation was calculated with
respect to total TrkA levels for each condition and was plotted relative to that of untreated cells in the presence of the indicated NT. n ¼ 4, *P < 0.05,
**P < 0.005. (D) Prolonged NGF treatment (60 min), increases the colocalization of CS-E and TrkA. Representative images show minimal colocalization in
untreated cells and increased colocalization (yellow) after treatment with NGF. The extent of colocalization was quantified as described in SI Methods
and plotted relative to that of untreated cells. n ¼ 24 cells. **P < 5 × 10−6.
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modulating interactions between specific NTs and their receptors.
Our computational modeling studies identify potential CS bind-
ing sites on NTs and other proteins. We also discover a contiguous
CS-E-binding site within the NT-Trk receptor complex, which sug-
gests a potential mechanism for how CS promotes complex for-
mation and modulates NT signaling. Taken together, we have
developed a general method for studying GAG–protein–protein
interactions that can be applied to screen various GAG subclasses
(HS, DS, CS, etc.) and particular sulfation motifs (CS-A, CS-E,
etc.) for the ability to assemble specific multimeric complexes.
The approach permits the identification of potentially low affinity
carbohydrate–protein–protein interactions that would be difficult
to study using existing methods. When combined with the com-
putational methods demonstrated herein, this strategy provides
unique molecular-level insights into the diverse biological func-
tions of GAGs.
Materials and Methods
Microarray analyses, computational methods, cellular assays, immunochem-
istry, and ELISA methods are described in SI Appendix, SI Methods.
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